304
Participants
Start Date
December 31, 2011
Primary Completion Date
March 31, 2014
Study Completion Date
August 31, 2014
Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
Participants in the VEGF Trap-Eye group received intravitreal injections every 8 weeks following a loading phase with injections given every 4 weeks for an overall treatment period of 48 weeks. Additionally, sham PDT treatments was administered as needed.
Visudyne
Participants in the PDT group (Visudyne group) received Visudyne as needed. Additionally, sham IVT injections was administered until week 28. Thereafter, subjects in the PDT group received active (= no sham) VEGF Trap-Eye treatment until week 48.
Beijing
Beijing
Beijing
Tianjin
Hangzhou
Hangzhou
Changsha
Guangzhou
Chengdu
Xi'an
Beijing
Qingdao
Wenzhou
Shanghai
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Bayer
INDUSTRY